These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37047229)

  • 21. Axl is related to inflammation in hemodialysis patients.
    Li M; Xue W; Li X; Song Y; Liu X; Qin L
    Mol Immunol; 2021 May; 133():146-153. PubMed ID: 33667984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible Association of Elevated Plasma Levels of Growth Arrest-Specific Protein 6 and the Soluble Form of Tyrosine Kinase Receptor Axl with Low Hepatitis C Viral Load in Patients with Type 2 Diabetes Mellitus.
    Bassyouni RH; Gomaa AA; Hassan EA; Ali ESG; Khalil MAF; Mashahit MA; Gaber SN
    Viral Immunol; 2020 Mar; 33(2):105-111. PubMed ID: 31905327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients.
    Tonello S; Rizzi M; Matino E; Costanzo M; Casciaro GF; Croce A; Rizzi E; Zecca E; Pedrinelli A; Vassia V; Landi R; Bellan M; Castello LM; Minisini R; Mallela VR; D'Onghia D; Avanzi GC; Pirisi M; Lilleri D; Sainaghi PP
    Dis Markers; 2022; 2022():1568352. PubMed ID: 35531477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behçets disease.
    Gheita TA; Bassyouni IH; Bassyouni RH
    J Clin Immunol; 2012 Dec; 32(6):1279-86. PubMed ID: 22833165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum.
    Budagian V; Bulanova E; Orinska Z; Duitman E; Brandt K; Ludwig A; Hartmann D; Lemke G; Saftig P; Bulfone-Paus S
    Mol Cell Biol; 2005 Nov; 25(21):9324-39. PubMed ID: 16227584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monocyte and plasma expression of TAM ligand and receptor in renal failure: Links to unregulated immunity and chronic inflammation.
    Lee IJ; Hilliard BA; Ulas M; Yu D; Vangala C; Rao S; Lee J; Gadegbeku CA; Cohen PL
    Clin Immunol; 2015 Jun; 158(2):231-41. PubMed ID: 25814173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study between polymorphims in GAS6-TAM genes and carotid atherosclerosis.
    Hurtado B; Abasolo N; Muñoz X; García N; Benavente Y; Rubio F; García de Frutos P; Krupinski J; Sala N
    Thromb Haemost; 2010 Sep; 104(3):592-8. PubMed ID: 20664904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin K Effects on Gas6 and Soluble Axl Receptors in Intensive Care Patients: An Observational Screening Study.
    Schött U; Augustsson C; Lilover L; Nilsson CU; Walther-Sturesson L; Kander T
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma concentrations predict aortic expression of growth-arrest-specific protein 6 in patients undergoing coronary artery bypass grafting.
    Lee CH; Shieh YS; Tsai CS; Hung YJ; Tsai YT; Lin CY
    PLoS One; 2013; 8(11):e79452. PubMed ID: 24236135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.
    Weinger JG; Omari KM; Marsden K; Raine CS; Shafit-Zagardo B
    Am J Pathol; 2009 Jul; 175(1):283-93. PubMed ID: 19541935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating growth arrest-specific 6 protein is associated with adiposity, systemic inflammation, and insulin resistance among overweight and obese adolescents.
    Hsiao FC; Lin YF; Hsieh PS; Chu NF; Shieh YS; Hsieh CH; Lee CH; Hung YJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E267-74. PubMed ID: 23341490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased soluble phagocytic receptors sMer, sTyro3 and sAxl and reduced phagocytosis in juvenile-onset systemic lupus erythematosus.
    Ballantine L; Midgley A; Harris D; Richards E; Burgess S; Beresford MW
    Pediatr Rheumatol Online J; 2015; 13():10. PubMed ID: 25878564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Plasma Growth Arrest-Specific 6 Protein Levels Are Associated with the Severity of Disease During Hantaan Virus Infection in Humans.
    Zhang C; Tang K; Zhang Y; Ma Y; Zhuang R; Zheng X; Jin B; Zhang Y
    Viral Immunol; 2017 Jun; 30(5):330-335. PubMed ID: 28537534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus.
    Suh CH; Hilliard B; Li S; Merrill JT; Cohen PL
    Arthritis Res Ther; 2010; 12(4):R146. PubMed ID: 20637106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.
    Gustafsson A; Martuszewska D; Johansson M; Ekman C; Hafizi S; Ljungberg B; Dahlbäck B
    Clin Cancer Res; 2009 Jul; 15(14):4742-9. PubMed ID: 19567592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin K-dependent proteins GAS6 and Protein S and TAM receptors in patients of systemic lupus erythematosus: correlation with common genetic variants and disease activity.
    Recarte-Pelz P; Tàssies D; Espinosa G; Hurtado B; Sala N; Cervera R; Reverter JC; de Frutos PG
    Arthritis Res Ther; 2013 Mar; 15(2):R41. PubMed ID: 23497733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis.
    Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC
    Dis Markers; 2019; 2019():2304931. PubMed ID: 31583026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity.
    Kimani SG; Kumar S; Bansal N; Singh K; Kholodovych V; Comollo T; Peng Y; Kotenko SV; Sarafianos SG; Bertino JR; Welsh WJ; Birge RB
    Sci Rep; 2017 Mar; 7():43908. PubMed ID: 28272423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gas6/TAM System and Multiple Sclerosis.
    Bellan M; Pirisi M; Sainaghi PP
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different expression patterns and clinical significance of mAxl and sAxl in systemic lupus erythematosus.
    Zhu H; Sun X; Zhu L; Hu F; Shi L; Fan C; Li Z; Su Y
    Lupus; 2014 Jun; 23(7):624-34. PubMed ID: 24474706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.